Status:
COMPLETED
A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes
Lead Sponsor:
Novartis
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-75 years
Phase:
PHASE2
Brief Summary
This study was not conducted in the United States. The purpose of this study was to assess the safety and effectiveness of a number of doses of vildagliptin, an unapproved drug, in the treatment of pe...
Eligibility Criteria
Inclusion
- Diagnosis of type 2 diabetes
- Patients who have been placed on diet and exercise therapy without achievement of glycemic control
- Outpatients
Exclusion
- Type 1 diabetes, diabetes that is a result of pancreatic injury, or secondary forms of diabetes
- Significant cardiovascular diseases
- Significant diabetic complications
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
291 Patients enrolled
Trial Details
Trial ID
NCT00238498
Start Date
July 1 2004
End Date
June 1 2005
Last Update
May 2 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.